SEC Form 4 research
| Issuer | REGENERON PHARMACEUTICALS INC |
|---|---|
| Tickers | REGN |
| Reporting owners | 38 |
| Officers and directors | 32 |
| Last public filing | 2026-11-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-06 | 2026-11-04 | Pitofsky Jason | S | 108 | $944.22 | Not reported |
| 2026-11-06 | 2026-11-04 | Pitofsky Jason | S | 529 | $943.53 | Not reported |
| 2026-11-06 | 2026-11-04 | Pitofsky Jason | S | 1,215 | $942.31 | Not reported |
| 2026-11-06 | 2026-11-04 | Pitofsky Jason | S | 982 | $941.58 | Not reported |
| 2026-11-06 | 2026-11-04 | Pitofsky Jason | S | 575 | $940.46 | Not reported |
| 2026-11-06 | 2026-11-04 | Pitofsky Jason | S | 439 | $939.57 | Not reported |
| 2026-11-06 | 2026-11-04 | Pitofsky Jason | S | 179 | $950.76 | Not reported |
| 2026-11-06 | 2026-11-04 | Pitofsky Jason | S | 35 | $945.61 | Not reported |
| 2026-11-05 | 2026-11-03 | Zoghbi Huda Y | S | 500 | $971.06 | Not reported |
| 2026-11-05 | 2026-11-03 | Zoghbi Huda Y | S | 6,939 | $970.42 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.